Diethylcarbamazine Citrate structure
|
Common Name | Diethylcarbamazine Citrate | ||
|---|---|---|---|---|
| CAS Number | 1642-54-2 | Molecular Weight | 391.417 | |
| Density | N/A | Boiling Point | 297.4ºC at 760 mmHg | |
| Molecular Formula | C16H29N3O8 | Melting Point | 140 °C | |
| MSDS | Chinese USA | Flash Point | 116.6ºC | |
| Symbol |
GHS06 |
Signal Word | Danger | |
Use of Diethylcarbamazine CitrateDiethylcarbamazine citrate is an inhibitor of arachidonic acid metabolism in filarial microfilaria; is highly specific for several parasites and does not contain any toxic metallic elements. |
| Name | N,N-Diethyl-4-methyl-1-piperazinecarboxamide Citrate |
|---|---|
| Synonym | More Synonyms |
| Description | Diethylcarbamazine citrate is an inhibitor of arachidonic acid metabolism in filarial microfilaria; is highly specific for several parasites and does not contain any toxic metallic elements. |
|---|---|
| Related Catalog | |
| References |
| Boiling Point | 297.4ºC at 760 mmHg |
|---|---|
| Melting Point | 140 °C |
| Molecular Formula | C16H29N3O8 |
| Molecular Weight | 391.417 |
| Flash Point | 116.6ºC |
| Exact Mass | 391.195465 |
| PSA | 158.92000 |
| Storage condition | -20°C Freezer |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H302-H330 |
| Precautionary Statements | P260-P301 + P312 + P330-P304 + P340 + P310-P403 + P233 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | T+: Very toxic; |
| Risk Phrases | R22 |
| Safety Phrases | S22-S36/37/39-S45 |
| RIDADR | UN 2811 6.1/PG 2 |
| WGK Germany | 3 |
| RTECS | TL1225000 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
| HS Code | 2933599090 |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Liquid chromatography-mass spectrometry analysis of diethylcarbamazine in human plasma for clinical pharmacokinetic studies.
J. Pharm. Biomed. Anal. 98 , 307-10, (2014) A sensitive and selective liquid chromatographic method using mass spectrometric detection was developed for the determination of diethylcarbamazine (DEC) in human plasma. DEC and its stable isotope i... |
|
|
Immunomodulatory effect of diethylcarbamazine in mice infected with Nocardia brasiliensis.
Int. Immunopharmacol. 23(1) , 113-20, (2015) We tested whether diethylcarbamazine (DEC) or ivermectin (IVM), both antiparasitic drugs with reported immunomodulatory properties, were able to affect the immune system to potentiate host defense mec... |
|
|
Loa loa—does it deserve to be neglected?
Lancet Infect. Dis. 14(4) , 353-7, (2014) More than 10 million people in western and central Africa are estimated to be infected with Loa loa filarial nematodes. Like most other infectious diseases, L loa filariasis (loiasis) covers a wide ra... |
| N,N-Diethyl-4-methylpiperazine-1-carboxamide 2-hydroxypropane-1,2,3-tricarboxylate (1:1) |
| 1-(N,N-DIETHYLCARBAMOYL)-4-METHYLPIPERAZINE CITRATE |
| MFCD00039124 |
| N,N-Diethyl-4-methyl-1-piperazinecarboxamide 2-hydroxy-1,2,3-propanetricarboxylate (1:1) |
| N,N-Diethyl-4-methyl-1-piperazinecarboxamide citrate salt |
| Diethylcarbamazine citrate |
| 1-Piperazinecarboxamide, N,N-diethyl-4-methyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt) |
| N,N-Diethyl-4-methyl-1-piperazinecarboxamide citrate salt,Diethylcarbamazine citrate salt |
| EINECS 216-696-6 |
| Diethylcarbamazine (citrate) |